Specialty pharmaceutical company Pharmaxis , which has Allan Gray fund manager Simon Marais on the shareholder register with 19.19 per cent, was the subject of takeover speculation over the weekend.

An offshore party is working up a bid proposal and has engaged an investment banking adviser, sources told Street Talk.